BGMS

Bio Green Med Solution, Inc. BGMS

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $10.1M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$357.0K

Quarter to Jun 30

Net income

$-405.0K

Quarter to Jun 30

Free cash flow

$-352.0K

Quarter to Jun 30

Operating margin

-117.1%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$93.1K total
CITADEL ADVISORS LLC
$68.5K+241.2%
JANE STREET GROUP, LLC
$14.8KNew
Tower Research Capital LLC (TRC)
$5.2K+34.3%
UBS Group AG
$3.9K+99.7%
SBI Securities Co., Ltd.
$638+40.2%
Archer Investment Corp
$10.0%
OSAIC HOLDINGS, INC.
$00.0%
See all 7 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/BGMS

Earnings Per Share

13fpro.ai/company/BGMS

Loading ratio trend…

BGMS key financials by period

Reported revenue, net income and operating margin by fiscal year, from Bio Green Med Solution, Inc.'s annual filings on SEC EDGAR.

Bio Green Med Solution, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2024$43.0K$-11.2M—
FY 2023$420.0K$-22.6M—
FY 2018$150.0K$-7.3M—
FY 2016$843.0K$-11.8M—
FY 2015$1.9M$-14.3M—
FY 2014$1.7M$-19.4M—
Source: BGMS filings on SEC EDGAR →

About Bio Green Med Solution, Inc. (BGMS): stock profile, AI score and financials

Bio Green Med Solution, Inc. (BGMS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. BGMS is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $10.1m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Bio Green Med Solution, Inc. reports quarterly revenue of $357.0K, net income of $-405.0K, an operating margin of -117.1%. Top institutional holders of BGMS by reported 13-F value include CITADEL ADVISORS, JANE STREET GROUP, Tower Research Capital (TRC), based on the most recent SEC filings. BGMS trades on the Nasdaq exchange and files with the SEC under CIK 1130166. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BGMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bio Green Med Solution, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1130166 →